Literature DB >> 11354674

DNA binding properties of the marine sponge pigment fascaplysin.

A Hörmann1, B Chaudhuri, H Fretz.   

Abstract

Association of fascaplysin with double-stranded calf thymus DNA was investigated by means of isothermal titration calorimetry, absorption spectroscopy, and circular dichroism. The UV spectroscopic data could be well interpreted in terms of a two-site model for the binding of fascaplysin to DNA revealing affinity constants of K1 = 2.5 x 10(6) M(-1) and K2 = 7.5 x 10(4) M(-1) (base pairs of DNA). Based on the typical change observed in the absorption and circular dichroism spectra, intercalation of fascaplysin is regarded as the major binding mode. The calorimetric titration curves showed an exothermic reaction which was exhausted at a 2:1 base pair/drug; ratio. This finding is in agreement with an intercalation model comprising nearest neighbor exclusion. In addition, significantly weaker non-intercalative DNA interactions can be observed at high drug concentration. By comparison of all these data with the binding behavior of known intercalating agents, it is concluded that fascaplysin intercalates into DNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354674     DOI: 10.1016/s0968-0896(00)00313-8

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

Review 1.  A new paradigm for the development of anticancer agents from natural products.

Authors:  Balanehru Subramanian; Alexander Nakeff; Karen Tenney; Phillip Crews; Leslie Gunatilaka; Fred Valeriote
Journal:  J Exp Ther Oncol       Date:  2006

2.  3-bromohomofascaplysin A, a fascaplysin analogue from a Fijian Didemnum sp. ascidian.

Authors:  Zhenyu Lu; Yuanqing Ding; Xing-Cong Li; Daignon R Djigbenou; Brian T Grimberg; Daneel Ferreira; Chris M Ireland; Ryan M Van Wagoner
Journal:  Bioorg Med Chem       Date:  2011-06-01       Impact factor: 3.641

3.  Divergent pathways in the biosynthesis of bisindole natural products.

Authors:  Katherine S Ryan; Catherine L Drennan
Journal:  Chem Biol       Date:  2009-04-24

4.  Discovery of indolotryptoline antiproliferative agents by homology-guided metagenomic screening.

Authors:  Fang-Yuan Chang; Sean F Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-09       Impact factor: 11.205

5.  Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.

Authors:  T Mahgoub; A J Eustace; D M Collins; N Walsh; N O'Donovan; J Crown
Journal:  Int J Oncol       Date:  2015-07-21       Impact factor: 5.650

6.  Cytotoxic effects of fascaplysin against small cell lung cancer cell lines.

Authors:  Gerhard Hamilton
Journal:  Mar Drugs       Date:  2014-03-07       Impact factor: 5.118

7.  Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK.

Authors:  Taek-In Oh; Jun Ho Lee; Seongman Kim; Taek-Jin Nam; Young-Seon Kim; Byeong Mo Kim; Woo Jong Yim; Ji-Hong Lim
Journal:  Molecules       Date:  2017-12-24       Impact factor: 4.411

8.  Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines.

Authors:  Barbara Rath; Maximilian Hochmair; Adelina Plangger; Gerhard Hamilton
Journal:  Mar Drugs       Date:  2018-10-14       Impact factor: 5.118

9.  Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization.

Authors:  S Mahale; S B Bharate; S Manda; P Joshi; P R Jenkins; R A Vishwakarma; B Chaudhuri
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.

Authors:  Emmanuel Ampofo; Thomas Später; Isabelle Müller; Hermann Eichler; Michael D Menger; Matthias W Laschke
Journal:  Mar Drugs       Date:  2015-11-09       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.